The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers (Q37767615)

22 August 2017

1 reference

title

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers (English)

1 reference

22 August 2017

0 references

0 references

3

Sunil R Lakhani

1 reference

22 August 2017

Ana Cristina Vargas

1

1 reference

22 August 2017

Leonard Da Silva

series ordinal

2

1 reference

22 August 2017

publication date

1 December 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

545-553

1 reference

Cancer Incidence in BRCA1 mutation carriers

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9362-5

Validity of models for predicting BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9362-5

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9362-5

Molecular and in silico analysis of BRCA1 and BRCA2 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9362-5

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

12 December 2020

Expression of BRCA1 protein in breast cancer and its prognostic significance

1 reference

12 December 2020

Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance

1 reference

12 December 2020

Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

1 reference

12 December 2020

Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations

1 reference

12 December 2020

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

1 reference

12 December 2020

Cancer susceptibility and the functions of BRCA1 and BRCA2

1 reference

12 December 2020

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods

1 reference

12 December 2020

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

1 reference

12 December 2020

Application of breast cancer risk prediction models in clinical practice

1 reference

12 December 2020

Establishing a cancer risk evaluation program

1 reference

12 December 2020

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium

1 reference

12 December 2020

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

12 December 2020

The pathology of inherited breast cancer

1 reference

12 December 2020

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

1 reference

12 December 2020

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

1 reference

12 December 2020

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

1 reference

12 December 2020

Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance

1 reference

12 December 2020

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

1 reference

12 December 2020

Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants

1 reference

12 December 2020

Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

1 reference

12 December 2020

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

12 December 2020

Low expression of bcl-2 in Brca1-associated breast cancers

1 reference

12 December 2020

Histopathological features of breast cancer in carriers of ATM gene variants

1 reference

12 December 2020

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Incorporating tumour pathology information into breast cancer risk prediction algorithms

1 reference

12 December 2020

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

1 reference

12 December 2020

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study

1 reference

12 December 2020

p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.

1 reference

12 December 2020

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families

1 reference

12 December 2020

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

1 reference

12 December 2020

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

1 reference

12 December 2020

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

1 reference

12 December 2020

Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

1 reference

12 December 2020

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

1 reference

12 December 2020

Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling

1 reference

12 December 2020

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

12 December 2020

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

1 reference

12 December 2020

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

1 reference

12 December 2020

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

1 reference

12 December 2020

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

1 reference

12 December 2020

Ductal carcinoma in situ in BRCA mutation carriers

1 reference

12 December 2020

Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

1 reference

12 December 2020

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

1 reference

12 December 2020

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

1 reference

12 December 2020

Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma

1 reference

12 December 2020

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

1 reference

12 December 2020

Breast and ovarian cancer

1 reference

12 December 2020

Prophylactic oophorectomy in inherited breast/ovarian cancer families

1 reference

12 December 2020

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

1 reference

12 December 2020

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

12 December 2020

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

1 reference

12 December 2020

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

1 reference

12 December 2020

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

1 reference

12 December 2020

Limited family structure and BRCA gene mutation status in single cases of breast cancer

1 reference

12 December 2020

Familial breast and ovarian cancer: a Swedish population-based register study

1 reference

12 December 2020

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

12 December 2020

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

1 reference

12 December 2020

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

12 December 2020

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

12 December 2020

A breast cancer prediction model incorporating familial and personal risk factors.

1 reference

12 December 2020

Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.

1 reference

12 December 2020

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

1 reference

12 December 2020

Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

1 reference

12 December 2020

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

1 reference

12 December 2020

Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States

1 reference

12 December 2020

Classification of missense variants of unknown significance inBRCA1based on clinical and tumor information

1 reference

12 December 2020

High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

1 reference

12 December 2020

Histopathological criteria and selection algorithms for BRCA1 genetic testing.

1 reference

12 December 2020

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

12 December 2020

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

1 reference

12 December 2020

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

1 reference

12 December 2020

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

1 reference

12 December 2020

Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center

1 reference

12 December 2020

BRCA1 dysfunction in sporadic basal-like breast cancer

1 reference

12 December 2020

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2

1 reference

12 December 2020

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2

1 reference

12 December 2020

Update on the Manchester Scoring System for BRCA1 and BRCA2 testing

1 reference

12 December 2020

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

1 reference

12 December 2020

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

1 reference

12 December 2020

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

1 reference

12 December 2020

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

12 December 2020

10.1007/S10689-010-9362-5

Identifiers

DOI

1 reference

22 August 2017

1 reference